Alex Pall Speaks on Working with Andrew Taggart and Creating “Closer”

In a recent article posted by, a member of The Chainsmokers, Alex Pall, was interviewed about the band’s recent track “Closer” and how working with his partner, Andrew Taggart has changed his life.

When asked how the two men met, Alex Pall revealed that he shared a mutual manager with his bandmate before they knew each other. They were both DJing in their free time and trying to find a way to integrate the dance styled music that they were passionate about into something more than a hobby. After meeting Taggart, the two hit it off instantly and began working together right away. They knew they were onto something big when Taggart moved down from Maine to New York and Pall quit his job at a New York art gallery. Pall was amazed to have found someone who understood his creative direction.

The duo admitted to being worried about building a unique identity in the electronic genre of music. It was a balancing act of creating something that would fit in with the current trends, but would also stand out among the thousands of other songs being made at the same time. A breakthrough came when Pall and Taggart decided to stop formatting themselves and just produce whatever they wanted to. It seems to have paid out with The Chainsmokers growing in popularity, earning themselves five Top 10 Hits and one Number One Hit.

With Alex Pall and Andrew Taggart both being DJs, selecting additional artists to be included in a song is a common occurrence. Their Number One Hit “Closer” featured Halsey, a singer and songwriter, and was an instant success. When asked how the process went, Pall stated that it had gone incredibly. The duo had been wanting to work with Halsey for some time and when Taggart and a friend began writing the lyrics to “Closer” they knew that there would be no one else for the job. Pall said Halsey’s voice was strong and unapologetic, which helped the song stand out. They hope to be working with more outstanding artists in the future as they continue to produce music.

5 AM Ventures – The Amazing Contributions of Dr. Scott M. Rocklage

Dr. Scott Rocklage is truly a one-of-a-kind individual. He is probably one of the most talented individuals that you have never heard of. He started out his illustrious career with receiving a B.S. in Chemistry from the University of California at Berkeley and later received his PhD in Chemistry from the Massachusetts Institute of Technology. One of the defining goals of Dr. Rocklage’s life has always been to help people through the use of drug development. Of course, he has taken a specific approach to accomplishing this goal. Consider the following:


Dr. Rocklage realizes that you must surround yourself with the right people to plant the seeds of success later on.


One of the most important guiding principles of Dr. Rocklage’s life would be getting in the right relationships. As one example, Dr. Rocklage did research in the laboratory of Richard R. Schrock, who won the 2005 Nobel Prize in Chemistry.


Dr. Rocklage is one determined individual.


One of the things Dr. Rocklage realizes is that bringing a drug to market is a lengthy process. It can be an extremely frustrating process, and whole career can be spent on just bringing a couple drugs to market. However, Dr. Rocklage is dedicated to this process because he realizes that many lives can be saved with even one important drug getting to the right individuals ( It is truly much like that commercial that talks about all of the sleepless nights, frustration and rejections from the FDA but when the drug is finally approved it saves the life of the speaker. Rocklage believes wholeheartedly in the process.


Dr. Rocklage has brought three such drugs to the market.


Finally, Dr. Rocklage has been instrumental in bringing three drugs to the market, including Omniscan, Teslascan and Cubicin. Omniscan helps individuals with brain disorders have more effective MRI results. Teslascan has been instrumental in helping with MRIs of the liver, and Cubicin assists with treatment of certain infections.


There is no question more dedicated medical researchers such as Dr. Scott Rocklage are needed. As he continues to work on introducing new drugs, one can only hope that his strong mentorship abilities will produce a new generation of drug researchers that are every bit as dedicated as he has always been.